Monitoring includes baseline and six-monthly liver function tests, NAFLD fibrosis risk stratification using FIB-4 score, and assessment for complications such as pancreatitis and gallbladder disease
Notably, the reduced expression of EZRa key regulator of cytoskeletal integrity and glucose metabolism (Bretscher et al
Those who recevied the placebo (no active drug) on average experienced 14% weight regain whilst those who continued on Tirzepatide had a further average weight loss of 5.5%
Of course a nice IM dosage of carnitine on my big carb days for sure
This built-in safety mechanism is why GLP-1 medications carry a much lower risk of hypoglycemia compared to insulin
Moreover, even if certain elimination diets are not recommended, patients should undergo evaluation for potential deficiencies of micronutrients and vitamins, especially in cases when gastrointestinal autoimmune comorbidities feature (Shaheen et al